3rd Chronic HBV Drug Development Summit

Key Topics

• Developing & Standardizing Predictive Biomarkers to Understand Disease Course & Shape Treatment Strategy
• Striving for Functional Cure: Advancing Combination Therapies to Attain Effective & Durable Treatment
• Enhancing Patient Recruitment & Stratification to Tailor Treatment to Subgroups
• Developing Reflective Models to Improve Mechanstic Understanding & Predict Efficacy of Antiviral Drugs & Novel Immunotherapies for HBV
• Paving the Way to Immunotherapeutics to Enhance Therapeutic Response in Combination Therapies
• Delineating Meaningful Endpoints & Stopping Points to Attain Durable Finite Treatment & Functional Cure
• Clinical Updates to Influence the Next Generation of Trials & Inform Pipeline Decisions